Study of Stapokibatrt in Children Subjects With Atopic Dermatitis

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

August 31, 2026

Conditions

Atopic Dermatitis

Interventions

BIOLOGICAL

Stapokibatrt

Stapokibatrt 1 or 2 ml,Subcutaneous injection(SC)

OTHER

Placebo

Placebo of matching volume，Subcutaneous injection(SC)

Trial Locations (1)

Beijing Children's Hospital Capital Medical University, Beijing